Related Experiment Video

Updated: Oct 25, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.2K

Unleashing the power of NK cells in anticancer immunotherapy

Meike Vogler1, Senthan Shanmugalingam2, Vinzenz Särchen2

  • 1Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstrasse 3a, 60528, Frankfurt, Germany. m.vogler@kinderkrebsstiftung-frankfurt.de.

Journal of Molecular Medicine (Berlin, Germany)
|August 10, 2021
PubMed

Insights

Natural killer (NK) cell immunotherapy shows promise for cancer treatment. Strategies focus on enhancing NK cell killing capacity or sensitizing tumor cells, particularly by modulating apoptosis signaling, to improve treatment efficacy.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Therapy

Background:

  • Natural killer (NK) cells possess inherent cytotoxic functions vital for eliminating damaged cells, making them promising candidates for cancer immunotherapy.
  • The efficacy of NK cell-mediated cytotoxicity is determined by a complex balance of regulatory signals originating from both NK cells and target tumor cells.

Purpose of the Study:

  • To review and present diverse strategies for optimizing NK cell immunotherapy in cancer treatment.
  • To highlight the potential of sensitizing tumor cells to NK cell attack, with a specific focus on modulating apoptosis signaling.

Main Methods:

  • This mini-review synthesizes existing research on NK cell immunotherapy strategies.
  • It focuses on analyzing methods to enhance NK cell activity and tumor cell susceptibility to NK cell-mediated lysis.

Main Results:

  • Combining NK cell therapy with agents that boost NK cell cytotoxicity or sensitize tumor cells is a key therapeutic avenue.
  • Modulating apoptosis signaling pathways within tumor cells can significantly enhance their vulnerability to NK cell-mediated killing.

Conclusions:

  • Unleashing the full potential of NK cell immunotherapy requires strategic approaches to optimize the NK cell-tumor cell interaction.
  • Targeting tumor cell apoptosis represents a viable strategy to improve the effectiveness of NK cell-based cancer treatments.
Keywords:
ApoptosisCancerImmunotherapyNatural killer cells

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.5K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

853

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.2K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
6.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
6.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
309
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581